Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousBiopsyWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationAnemia, AplasticTransplantation ConditioningLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHematopoietic Stem CellsHistocompatibility TestingHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationHematopoiesisRecurrenceCombined Modality TherapyMice, Inbred C57BLTime FactorsT-LymphocytesRadiation ChimeraBone Marrow ExaminationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteTreatment OutcomeImmunosuppressive AgentsGraft RejectionHematologic NeoplasmsRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingLeukemia, MyeloidTransplantation ImmunologyBone Marrow NeoplasmsImmunosuppressionLymphoma, Non-HodgkinAcute DiseaseLymphocyte DepletionGraft vs Host ReactionStem Cell TransplantationLeukocyte TransfusionHeart TransplantationColony-Forming Units AssayLeukocytes, MononuclearFlow CytometryRetrospective StudiesLeukocyte CountHLA AntigensChimeraSevere Combined ImmunodeficiencyCells, CulturedSurvival AnalysisMyelodysplastic SyndromesBiopsy, NeedleCyclosporineLung TransplantationLymphocytesHematologic DiseasesGranulocyte Colony-Stimulating FactorPeripheral Blood Stem Cell TransplantationCell DifferentiationLymphocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsBlood CellsBone DensityActuarial AnalysisFollow-Up StudiesSpleenAntigens, CD34Nuclear FamilyCarmustineImmunophenotypingPancytopeniaOrgan TransplantationCytomegalovirus InfectionsSurvival RateCytarabineGraft vs Tumor EffectMice, Inbred BALB CLymphomaGraft vs Leukemia EffectMelphalanMultiple MyelomaCell SeparationDisease-Free SurvivalAntigens, CDAntibodies, Monoclonal